Drugs Made In America Acquisition Corp. Files 2024 10-K

Ticker: DMAAR · Form: 10-K · Filed: Mar 31, 2025 · CIK: 2028614

Drugs Made In America Acquisition Corp. 10-K Filing Summary
FieldDetail
CompanyDrugs Made In America Acquisition Corp. (DMAAR)
Form Type10-K
Filed DateMar 31, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, spac

TL;DR

DMAA filed its 2024 10-K. Full financials and biz ops details inside.

AI Summary

Drugs Made In America Acquisition Corp. filed its 10-K for the fiscal year ended December 31, 2024. The company, incorporated in the Cayman Islands, is headquartered at 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301. The filing details its operations and financial status for the reporting period.

Why It Matters

This 10-K filing provides investors and stakeholders with a comprehensive overview of Drugs Made In America Acquisition Corp.'s financial performance and business operations for the fiscal year 2024.

Risk Assessment

Risk Level: low — This filing is a standard annual report and does not inherently indicate new or elevated risks for the company.

Key Numbers

  • 2024 — Fiscal Year End (The period covered by the 10-K filing.)
  • 001-42467 — SEC File Number (Identifies the company's filings with the SEC.)

Key Players & Entities

  • Drugs Made In America Acquisition Corp. (company) — Registrant
  • December 31, 2024 (date) — Fiscal year end
  • Cayman Islands (location) — Jurisdiction of incorporation
  • 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301 (address) — Principal executive offices
  • 001-42467 (other) — Commission file number

FAQ

What is the primary business of Drugs Made In America Acquisition Corp.?

The filing indicates the company's SIC code is 'BLANK CHECKS [6770]', suggesting it is a special purpose acquisition company (SPAC).

When did the fiscal year covered by this 10-K report end?

The fiscal year ended on December 31, 2024.

Where is Drugs Made In America Acquisition Corp. headquartered?

The company's principal executive offices are located at 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301.

What is the company's commission file number?

The commission file number for Drugs Made In America Acquisition Corp. is 001-42467.

In which jurisdiction was Drugs Made In America Acquisition Corp. incorporated?

The company was incorporated in the Cayman Islands.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding Drugs Made In America Acquisition Corp. (DMAAR).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.